HTG Molecular Diagnostics Inc. [NASDAQ:HTGM] prices stumbled -1.52% on Friday.
With a current price of $0.34, HTGM is active in the Diagnostics & Research industry and it looks to be on-track for a five-day run of 8.46%.
In addition, HTGM’s high over the last year is $0.99 and the low is $0.27. Over the last two 52 weeks, the company is trading -58.92%, while the S&P 500 is trading 1.11%.
The Bears are coming
Holding a Market Cap of $23.30 million, HTG Molecular Diagnostics Inc. has seen a trading range over the last year of $0.27-$0.99.
For the last five days, HTGM is up from its last closing price. The average shares trading hands each day is 3.70M, with average 10-day volume coming in at 1.58 million.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for HTGM. When we apply the Elder Force Index to HTG Molecular Diagnostics Inc., we are seeing an Elder Force Indicator number of 0.0.
Recent Performance
The company’s enterprise value has gone from $27.50M to -$1.56M quarter-over-quarter. Obviously, the company is heading in the wrong direction, but there are still opportunities for growth in the sector.
In the last quarter, HTGM made a profit of 0.99 million. HTG Molecular Diagnostics Inc. also saw quarter revenue growth year over year of -10.70%. In addition, the company has operating cash flow of -$16.31 million.
Technical Analysis
Looking at popular technical indicators, the company’s 5-day moving average is 0.3260 compared to the 50-day moving average of 0.3384. So, traders might want to tread carefully if they are going to bid.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. HTGM currently holds a 9-day RSI of 51.74%, while 100-day RSI stands at 44.95%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. HTGM’s 9-day MACD is 0.0114 and the company’s 100-day MACD stands at -0.1926.
Inside Moves
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 7.87% by insiders and 58.10% by institutions. Regarding institutional holdings, Nantahala Capital Management, LLC owns 7.16%, while the second top holder, Cowen Prime Services LLC, currently owns 6.48%.
Over the last six months, insiders have sold 5,718 with the most recent transaction from JOHNSON TIM B, Executive Chairman, with a sell at price 0.72 per share.
Conclusion
Overall, the recommended rating for HTGM is Moderate Buy. Currently, the company has 4 analysts watching the stock, and the average quarterly earnings estimate is -0.08. Quarterly revenue estimates are averaging 2.23M with the high estimate reaching 2.5M and the low at 2M.
